194 related articles for article (PubMed ID: 37477937)
21. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature.
Prakash S; Sarran L; Socci N; DeMatteo RP; Eisenstat J; Greco AM; Maki RG; Wexler LH; LaQuaglia MP; Besmer P; Antonescu CR
J Pediatr Hematol Oncol; 2005 Apr; 27(4):179-87. PubMed ID: 15838387
[TBL] [Abstract][Full Text] [Related]
22. Oncogene mutational analysis in imatinib naive population of gastrointestinal stromal tumor patients.
Ali Abuderman AW; M Aldakheel F
Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):26-32. PubMed ID: 34174973
[TBL] [Abstract][Full Text] [Related]
23. Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.
Heinrich MC; Rankin C; Blanke CD; Demetri GD; Borden EC; Ryan CW; von Mehren M; Blackstein ME; Priebat DA; Tap WD; Maki RG; Corless CL; Fletcher JA; Owzar K; Crowley JJ; Benjamin RS; Baker LH
JAMA Oncol; 2017 Jul; 3(7):944-952. PubMed ID: 28196207
[TBL] [Abstract][Full Text] [Related]
24. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
[TBL] [Abstract][Full Text] [Related]
25. Molecular research directions in the management of gastrointestinal stromal tumors.
Tarn C; Godwin AK
Curr Treat Options Oncol; 2005 Nov; 6(6):473-86. PubMed ID: 16242052
[TBL] [Abstract][Full Text] [Related]
26. Exon 11 homozygous mutations and intron 10/exon 11 junction deletions in the KIT gene are associated with poor prognosis of patients with gastrointestinal stromal tumors.
Shen YY; Ma XL; Wang M; Zhuang C; Ni B; Tu L; Liu Q; Zhao WY; Cao H
Cancer Med; 2020 Sep; 9(18):6485-6496. PubMed ID: 32697050
[TBL] [Abstract][Full Text] [Related]
27. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
Li JX; Sun L; Zhao S; Shao B; Guo YH; Chen S; Liang H; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):346-356. PubMed ID: 37072312
[No Abstract] [Full Text] [Related]
28. Presence of homozygous KIT exon 11 mutations is strongly associated with malignant clinical behavior in gastrointestinal stromal tumors.
Lasota J; vel Dobosz AJ; Wasag B; Wozniak A; Kraszewska E; Michej W; Ptaszynski K; Rutkowski P; Sarlomo-Rikala M; Steigen SE; Schneider-Stock R; Stachura J; Chosia M; Ogun G; Ruka W; Siedlecki JA; Miettinen M
Lab Invest; 2007 Oct; 87(10):1029-41. PubMed ID: 17632543
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic targets in gastrointestinal stromal tumors].
Wardelmann E; Schildhaus HU; Merkelbach-Bruse S; Büttner R
Verh Dtsch Ges Pathol; 2006; 90():73-9. PubMed ID: 17867582
[TBL] [Abstract][Full Text] [Related]
30. Genomic profiling in GIST: Implications in clinical outcome and future challenges.
Calderillo-Ruíz G; Pérez-Yepez EA; García-Gámez MA; Millan-Catalan O; Díaz-Romero C; Ugalde-Silva P; Salas-Benavides R; Pérez-Plasencia C; Carbajal-López B
Neoplasia; 2024 Feb; 48():100959. PubMed ID: 38183711
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
32. Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?
Sendur MA; Ozdemir NY; Akinci MB; Uncu D; Zengin N; Aksoy S
World J Gastroenterol; 2013 Jan; 19(1):144-6. PubMed ID: 23326179
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of an Italian series of sporadic GISTs.
Origone P; Gargiulo S; Mastracci L; Ballestrero A; Battistuzzi L; Casella C; Comandini D; Cusano R; Dei Tos AP; Fiocca R; Garuti A; Ghiorzo P; Martinuzzi C; Toffolatti L; ; Bianchi Scarrà G
Gastric Cancer; 2013 Oct; 16(4):596-601. PubMed ID: 23291969
[TBL] [Abstract][Full Text] [Related]
34. KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
Incorvaia L; De Biase D; Nannini M; Fumagalli E; Vincenzi B; De Luca I; Brando C; Perez A; Pantaleo MA; Gasperoni S; D'Ambrosio L; Grignani G; Maloberti T; Pedone E; Bazan Russo TD; Mazzocca A; Algeri L; Dimino A; Barraco N; Serino R; Gristina V; Galvano A; Bazan V; Russo A; Badalamenti G
Oncologist; 2024 Jan; 29(1):e141-e151. PubMed ID: 37463014
[TBL] [Abstract][Full Text] [Related]
35. KIT Exon 9-Mutated Gastrointestinal Stromal Tumours: Biology and Treatment.
Napolitano A; Thway K; Smith MJ; Huang PH; Jones RL
Chemotherapy; 2022; 67(2):81-90. PubMed ID: 34983047
[TBL] [Abstract][Full Text] [Related]
36. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Corless CL; Ballman KV; Antonescu CR; Kolesnikova V; Maki RG; Pisters PW; Blackstein ME; Blanke CD; Demetri GD; Heinrich MC; von Mehren M; Patel S; McCarter MD; Owzar K; DeMatteo RP
J Clin Oncol; 2014 May; 32(15):1563-70. PubMed ID: 24638003
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.
Patrikidou A; Domont J; Chabaud S; Ray-Coquard I; Coindre JM; Bui-Nguyen B; Adenis A; Rios M; Bertucci F; Duffaud F; Chevreau C; Cupissol D; Pérol D; Emile JF; Blay JY; Le Cesne A;
Eur J Cancer; 2016 Jan; 52():173-80. PubMed ID: 26687836
[TBL] [Abstract][Full Text] [Related]
38. Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing.
Hechtman JF; Zehir A; Mitchell T; Borsu L; Singer S; Tap W; Oultache A; Ladanyi M; Nafa K
Genes Chromosomes Cancer; 2015 Mar; 54(3):177-84. PubMed ID: 25427437
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review.
Ding H; Yu X; Yu Y; Lao X; Hang C; Gao K; Jia Y; Yan Z
Oncol Rep; 2020 Mar; 43(3):751-764. PubMed ID: 32020209
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls.
Torrence D; Xie Z; Zhang L; Chi P; Antonescu CR
Genes Chromosomes Cancer; 2021 Dec; 60(12):789-795. PubMed ID: 34398495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
